Cassava production in sub-Saharan Africa is significantly constrained by two viral diseases; cassava brown streak disease (CBSD) and cassava mosaic disease (CMD). The Virus Resistant Cassava for Africa (VIRCA) project aims to deliver transgenic virus resistant varieties to farmers in East Africa. In this paper, we examine progress made, opportunities and challenges. VIRCA presents an opportunity for long term management of CBSD and CMD, based on developing virus resistant versions of farmer-preferred cultivars, which retain their desirable agronomic and storage root quality attributes. To-date, proof-of-concept for control of viral pathogens of both diseases using RNAi technology has been demonstrated in the greenhouse, and in approved confined field trials (CFTs) conducted in Uganda and Kenya. Target cultivars for product development have been identified, their transformation to generate transgenic events is on-going, with CFT regulatory approval for event selection field testing in Uganda expected in 2012. An integrated field trial program has been designed for trait selection, agronomic performance trials and data colletion for compilation of the dossier seeking regulatory approval for commercialization. These activities are supported by communication efforts and plans for dissemination of the virus resistant varieties to farmers in the region. Capacity in East Africa to develop and field test VIRCA products though still limited is available and growing. Scientists with required skills and competencies exist in the national systems and are willing to collaborate in VIRCA activities. Furthermore, supportive national policies and regulatory mechanisms already exist in the project countries. Several technical challenges such as development of efficacious gene constructs and genetic transformation of cassava landraces have been overcome. On going challenges being addressed to facilitate full deployment of VIRCA products including in-region perception regarding risks posed by GM crops and continued development of the appropriate regulatory systems to guide deregulation of staple crops and the costs involved.

